The first study to demonstrate the potential of variants in miRNA processing genes as a predictor of toxicity in the pharmacological management of ALL linked rs639174 in DROSHA to MTX-induced gastrointestinal toxicity in pediatric patients with B-cell ALL [19,21]. The gene discussed is DROSHA; the disease is acute lymphoblastic leukemia.